KHIANNA BRYANT: Open Payments
NPI 1063269439 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
| Novo Nordisk Inc | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Lilly USA, LLC | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: AUSTEDO XR, Kerendia, Rybelsus, BREZTRI, JARDIANCE, GVOKE HYPOPEN.
Industry payments across MD — which companies pay providers there.
